King H, Rewers M
Diabetes and Other Noncommunicable Diseases Unit, World Health Organization, Geneva, Switzerland.
Diabetes Care. 1993 Jan;16(1):157-77. doi: 10.2337/diacare.16.1.157.
To assemble standardized estimates of abnormal glucose tolerance in adults in diverse communities worldwide and provide guidelines for the derivation of comparable estimates in future epidemiological studies.
The project was limited to population-based investigations that had used current WHO criteria for diagnosis and classification of abnormal glucose tolerance. Raw data were obtained by WHO from surveys conducted during 1976-1991 of over 150,000 persons from 75 communities in 32 countries. Data within the truncated age range of 30-64 yr were adjusted to the standard world population of Segi. Age-specific prevalences also are reported for selected populations.
Within the chosen age range, diabetes was absent or rare (< 3%) in some traditional communities in developing countries. In European populations, age-standardized prevalence varied from 3 to 10%. Some Arab, migrant Asian Indian, Chinese, and Hispanic American populations were at higher risk with prevalences of 14-20%. The highest prevalences were found in the Nauruans (41%) and the Pima/Papago Indians (50%). Age-standardized prevalence of IGT was low (< 3%) in some Chinese, traditional American Indian, and Pacific island populations. Moderate (3-10%) or high (11-20%) prevalences of IGT were observed in many populations worldwide. The highest estimates for prevalence of IGT were seen in female Muslim Asian Indians in Tanzania (32%) and in urban male Micronesians in Kiribati (28%). Prevalence of diabetes rose with age in all populations in which age-specific data were examined. This trend was most pronounced in those at moderate to high risk. The ratio of prevalence of diabetes in men versus women varied markedly between populations with little discernable trend, although IGT was generally more common in women. In most communities, at least 20% of diabetes cases were unknown before the survey, and in many communities, > 50% were previously undiagnosed. In both Chinese and Indian migrant populations, relative prevalence was high when compared with indigenous communities.
Diabetes in adults is now a global health problem, and populations of developing countries, minority groups, and disadvantaged communities in industrialized countries now face the greatest risk.
汇总全球不同社区成年人糖耐量异常的标准化估计值,并为未来流行病学研究得出可比估计值提供指导。
该项目仅限于基于人群的调查,这些调查采用了世界卫生组织当前关于糖耐量异常诊断和分类的标准。世界卫生组织从1976 - 1991年期间对32个国家75个社区的15万多人进行的调查中获取了原始数据。将截断年龄范围在30 - 64岁的数据调整为Segi标准世界人口数据。还报告了特定人群的年龄别患病率。
在选定的年龄范围内,发展中国家的一些传统社区中糖尿病不存在或很罕见(<3%)。在欧洲人群中,年龄标准化患病率在3%至10%之间。一些阿拉伯、亚洲印度裔移民、华裔和西班牙裔美国人群风险较高,患病率为14% - 20%。瑙鲁人(41%)和皮马/帕帕戈印第安人(50%)的患病率最高。在一些华裔、传统美洲印第安人和太平洋岛屿人群中,糖耐量受损(IGT)的年龄标准化患病率较低(<3%)。在全球许多人群中观察到IGT的患病率为中度(3% - 10%)或高度(11% - 20%)。IGT患病率的最高估计值出现在坦桑尼亚的亚洲印度裔穆斯林女性(32%)和基里巴斯城市密克罗尼西亚男性(28%)中。在所有检查了年龄别数据的人群中,糖尿病患病率随年龄增长而上升。这种趋势在中高风险人群中最为明显。尽管IGT在女性中通常更常见,但不同人群中男性与女性糖尿病患病率之比差异显著,几乎没有明显趋势。在大多数社区中,至少20%的糖尿病病例在调查前未被发现,在许多社区中,>50%的病例此前未被诊断。在华裔和印度裔移民人群中,与本土社区相比相对患病率较高。
成年人糖尿病现在是一个全球健康问题,发展中国家的人群、少数群体以及工业化国家处境不利的社区现在面临的风险最大。